Clinical outcomes of patients after nipple-sparing mastectomy and reconstruction based on the expander/implant technique

por Toh, Uhi, Takenaka, Miki, Iwakuma, Nobutaka, Akagi, Yoshito
Publicado 2020

Immune responses of patients without cancer recurrence after a cancer vaccine over a long term

por Suekane, Shigetaka, Yutani, Shigeru, Toh, Uhi, Yoshiyama, Koichi, Itoh, Kyogo
Publicado 2022

Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer

por Mishima, Mai, Toh, Uhi, Iwakuma, Nobutaka, Takenaka, Miki, Furukawa, Mina, Akagi, Yoshito
Publicado 2014

Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines

por Saku, Shuko, Toh, Uhi, Takao, Yuko, Sakurai, Sayaka, Yamada, Akira, Shichijo, Shigeki, Itoh, Kyogo, Akagi, Yoshito
Publicado 2021

Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case

por Muroya, Daisuke, Toh, Uhi, Iwakuma, Nobutaka, Nakagawa, Shino, Mishima, Mai, Takahashi, Ryuji, Takenaka, Miki, Shirouzu, Kazuo, Agaki, Yoshito
Publicado 2014

Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer

por Toh, Uhi, Sakurai, Sayaka, Saku, Shuko, Takao, Yuko, Okabe, Mina, Iwakuma, Nobutaka, Shichijo, Shigeki, Yamada, Akira, Itoh, Kyogo, Akagi, Yoshito
Publicado 2020

Predictive factors of the tumor immunological microenvironment for long‐term follow‐up in early stage breast cancer

por Okabe, Mina, Toh, Uhi, Iwakuma, Nobutaka, Saku, Shuko, Akashi, Momoko, Kimitsuki, Yuko, Seki, Naoko, Kawahara, Akihiko, Ogo, Etsuyo, Itoh, Kyogo, Akagi, Yoshito
Publicado 2017

Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy

por TAKAHASHI, RYUJI, TOH, UHI, IWAKUMA, NOBUTAKA, MISHIMA, MAI, FUJII, TERUHIKO, TAKENAKA, MIKI, KOURA, KEIKO, SEKI, NAOKO, KAWAHARA, AKIHIKO, KAGE, MASHAYOSHI, OGO, ETSUYO, SHIROUZU, KAZUO
Publicado 2013

Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients

por Takahashi, Ryuji, Toh, Uhi, Iwakuma, Nobutaka, Takenaka, Miki, Otsuka, Hiroko, Furukawa, Mina, Fujii, Teruhiko, Seki, Naoko, Kawahara, Akihiko, Kage, Masayoshi, Matsueda, Satoko, Akagi, Yoshito, Yamada, Akira, Itoh, Kyogo, Sasada, Tetsuro
Publicado 2014

Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele

por Sakamoto, Shinjiro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Noguchi, Masanori, Yutani, Shigeru, Yamada, Akira, Shichijo, Shigeki, Yamada, Teppei, Suekane, Shigetaka, Kawano, Kouichiro, Sasada, Tetsuro, Hattori, Noboru, Kohno, Nobuoki, Itoh, Kyogo
Publicado 2015

Immunological evaluation of peptide vaccination for cancer patients with the HLA ‐A11(+) or ‐A33(+) allele

por Sakamoto, Shinjiro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Noguchi, Masanori, Yutani, Shigeru, Yamada, Akira, Shichijo, Shigeki, Yamada, Teppei, Suekane, Shigetaka, Kawano, Kouichiro, Naitou, Masayasu, Sasada, Tetsuro, Hattori, Noboru, Kohno, Nobuoki, Itoh, Kyogo
Publicado 2017

Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japa...

por Watanabe, Kenichi, Niikura, Naoki, Kikawa, Yuichiro, Oba, Mari, Kobayashi, Kokoro, Tada, Hiroshi, Ozaki, Shinji, Toh, Uhi, Yamamoto, Yutaka, Tsuneizumi, Michiko, Okuno, Toshitaka, Iwakuma, Nobutaka, Takeshita, Takashi, Iwamoto, Takayuki, Ishiguro, Hiroshi, Masuda, Norikazu, Saji, Shigehira
Publicado 2023

FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis

por TAKENAKA, MIKI, SEKI, NAOKO, TOH, UHI, HATTORI, SATOSHI, KAWAHARA, AKIHIKO, YAMAGUCHI, TOMOHIKO, KOURA, KEIKO, TAKAHASHI, RYUJI, OTSUKA, HIROKO, TAKAHASHI, HIROKI, IWAKUMA, NOBUTAKA, NAKAGAWA, SHINO, FUJII, TERUHIKO, SASADA, TETSURO, YAMAGUCHI, RIN, YANO, HIROHISA, SHIROUZU, KAZUO, KAGE, MASAYOSHI
Publicado 2013

Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients

por Suekane, Shigetaka, Yutani, Shigeru, Yamada, Akira, Sasada, Tetsuro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Kawano, Kouichiro, Yoshiyama, Koichi, Sakamoto, Shinjiro, Sugawara, Shunichi, Komatsu, Nobukazu, Yamada, Teppei, Naito, Masayasu, Terasaki, Mizuhiko, Mine, Takashi, Itoh, Kyogo, Shichijo, Shigeki, Noguchi, Masanori
Publicado 2020

Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)

por Futamura, Manabu, Oba, Mari, Masuda, Norikazu, Bando, Hiroko, Okada, Morihito, Yamamoto, Yutaka, Kin, Takanori, Saeki, Toshiaki, Nagashima, Takeshi, Kuwayama, Takashi, Toh, Uhi, Hirano, Akira, Inokuchi, Masafumi, Yamagami, Kazuhiko, Mizuno, Yutaka, Kojima, Yasuyuki, Nakayama, Takahiro, Yasojima, Hiroyuki, Ohno, Shinji
Publicado 2021

Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHA...

por Yamamoto, Yutaka, Yamashiro, Hiroyasu, Toh, Uhi, Kondo, Naoto, Nakamura, Rikiya, Kashiwaba, Masahiro, Takahashi, Masato, Tsugawa, Koichiro, Ishikawa, Takashi, Nakayama, Takahiro, Ohtani, Shoichiro, Takano, Toshimi, Fujisawa, Tomomi, Toyama, Tatsuya, Kawaguchi, Hidetoshi, Mashino, Kojiro, Tanino, Yuichi, Morita, Satoshi, Toi, Masakazu, Ohno, Shinji
Publicado 2020